GlassScriptPhysician profile
Lewis T Ladocsi
NPI 1134164635
$4,576.06
in general payments reported to CMS, 2019-2025
15 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $562 · 2021: $1,362 · 2022: $960 · 2023: $117 · 2024: $357 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $2,041.58 | 2019-2022 | |
| Mentor Worldwide LLC | $1,032.52 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $468.42 | 2021-2023 | |
| Revance Therapeutics, INC. | $258.80 | 2024-2025 | Daxxify |
| Allergan, INC. | $216.54 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $202.54 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $75.01 | 2021 | |
| Abbvie INC. | $73.42 | 2023-2024 | |
| Integra Lifesciences Corporation | $66.09 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Apyx Medical Corporation | $32.75 | 2020 | |
| Misonix INC | $26.98 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.96 | 2019 | |
| Motiva USA, LLC | $22.22 | 2025 | |
| Medtronic, INC. | $17.12 | 2024 | V-Loc 180 |
| Galderma Laboratories, L.P. | $17.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Ladocsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.